Nicox Sa Stock Fundamentals
| NICXFDelisted Stock | USD 0.44 0.00 0.00% |
Nicox SA fundamentals help investors to digest information that contributes to Nicox SA's financial success or failures. It also enables traders to predict the movement of Nicox Pink Sheet. The fundamental analysis module provides a way to measure Nicox SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nicox SA pink sheet.
Nicox |
Nicox SA Company Return On Equity Analysis
Nicox SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nicox SA Return On Equity | -0.65 |
Most of Nicox SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nicox SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Nicox SA has a Return On Equity of -0.6454. This is 97.31% lower than that of the Healthcare sector and 98.23% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 108.19% higher than that of the company.
Nicox SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nicox SA's current stock value. Our valuation model uses many indicators to compare Nicox SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nicox SA competition to find correlations between indicators driving Nicox SA's intrinsic value. More Info.Nicox SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nicox SA's earnings, one of the primary drivers of an investment's value.Nicox Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nicox SA's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nicox SA could also be used in its relative valuation, which is a method of valuing Nicox SA by comparing valuation metrics of similar companies.Nicox SA is currently under evaluation in return on equity category among its peers.
Nicox Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0905 | |||
| Operating Margin | (2.29) % | |||
| Current Valuation | 54.64 M | |||
| Shares Outstanding | 50.16 M | |||
| Shares Owned By Insiders | 6.32 % | |||
| Shares Owned By Institutions | 17.02 % | |||
| Price To Earning | 146.39 X | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 5.91 X | |||
| Revenue | 8.58 M | |||
| Gross Profit | 7.23 M | |||
| EBITDA | (15.96 M) | |||
| Net Income | (43.76 M) | |||
| Cash And Equivalents | 41.97 M | |||
| Cash Per Share | 0.98 X | |||
| Total Debt | 20.52 M | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 5.97 X | |||
| Book Value Per Share | 1.41 X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Earnings Per Share | (1.23) X | |||
| Number Of Employees | 32 | |||
| Beta | 0.96 | |||
| Market Capitalization | 47.99 M | |||
| Total Asset | 114.61 M | |||
| Retained Earnings | (24 M) | |||
| Working Capital | 8 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 31 M | |||
| Z Score | 1.2 | |||
| Net Asset | 114.61 M |
About Nicox SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nicox SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nicox SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nicox SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Nicox Pink Sheet
If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |